Top Story
March 26, 2020
Read the
Perspective
from
Alexander Kutikov, MD, FACS
Risk for infection with SARS-CoV-2 — the novel coronavirus that causes COVID-19 — appeared more than twice as high among individuals with cancer than the general population, according to an analysis of data from a tertiary care hospital in Wuhan, China.
“We propose that aggressive measures be undertaken to reduce frequency of hospital visits of patients with cancer during a viral epidemic going forward,” Jing Yu, MD, of the department of radiation and medical oncology at Zhongnan Hospital of Wuhan University, and colleagues wrote in a research letter published in JAMA Oncology.
In the Journals
March 25, 2020
The novel HER2-targeted antibody-drug conjugate fam-trastuzumab deruxtecan-nxki appeared active in a cohort of patients with various heavily pretreated HER2-expressing…
March 17, 2020
The addition of durvalumab to a choice of standard-of-care first-line chemotherapies conferred a sustained OS benefit for patients with extensive-stage small cell lung…
FDA News
March 11, 2020
The FDA granted breakthrough therapy designation to JNJ-6372 for the treatment of certain patients with metastatic non-small cell lung cancer, according to the…